Furthermore, the risk of developing secondary diabetes for the patients with positive HER2 expression (HR = 1.822; 95 % CI 1.230–2.700 (P < 0.01)) was higher than for those with negative HER2 expression. The gene discussed is ERBB2; the disease is diabetes mellitus.